Marta Olejniczak
Poznan, WP 61704, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Challenges in visualizing endogenous loci in the human genome using CRISPR-based imaging systems.
Journal: Biotechnologia
Published: December 16, 2025
CRISPR/Cas9-induced double-strand breaks in the huntingtin locus lead to CAG repeat contraction through DNA end resection and homology-mediated repair.
Journal: BMC biology
Published: March 07, 2024
RNA regulation in brain function and disease 2022 (NeuroRNA): A conference report.
Journal: Frontiers in molecular neuroscience
Published: December 28, 2022
Advances in Modeling Polyglutamine Diseases Using Genome Editing Tools.
Journal: Cells
Published: January 04, 2022
A CAG repeat-targeting artificial miRNA lowers the mutant huntingtin level in the YAC128 model of Huntington's disease.
Journal: Molecular therapy. Nucleic acids
Published: September 11, 2021
Artificial miRNAs as therapeutic tools: Challenges and opportunities.
Journal: Wiley interdisciplinary reviews. RNA
Published: October 01, 2020
Paving the way towards precise and safe CRISPR genome editing.
Journal: Biotechnology advances
Published: July 24, 2020
Computational Tools and Resources Supporting CRISPR-Cas Experiments.
Journal: Cells
Published: May 06, 2020
Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology.
Journal: International journal of molecular sciences
Published: January 08, 2020
Artificial miRNAs targeting CAG repeat expansion in ORFs cause rapid deadenylation and translation inhibition of mutant transcripts.
Journal: Cellular and molecular life sciences : CMLS
Published: December 30, 2019
Gene Therapy for Huntington's Disease Using Targeted Endonucleases.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 06, 2019
Last Updated: 09/26/2026